Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway

Journal of Vascular Research

Volumn 37, Issue 3, 2000, Pages 209-218

  Nör, Jacques E ^a   Mitra, Raj S ^a   Sutorik, Michelle M ^a   Mooney, David J ^a   Castle, Valerie P ^a   Polverini, Peter J ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b 1011 N University   (United States)

Author keywords

Anglogenesis; Bax; Bcl 2; Caspase 3; Cysteine protease; Neovascularization; TSP1

Indexed keywords

CASPASE; CASPASE 3; PROTEIN BAX; PROTEIN BCL 2; THROMBOSPONDIN 1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0343091300     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000025733     Document Type: Article

References (35)

1. Lawler J: The structural and functional properties of thrombospondin. Blood 1986;67:1197-1209.
2. Bornstein P: Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin-1. J Cell Biol 1995;130:503-506.
3. O'Shea KS, Dixit VM: Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo. J Cell Biol 1988;107:2737-2748.
4. Taraboletti G, Roberts D, Liotta LA, Giavazzi R: Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: A potential angiogenesis regulatory factor. J Cell Biol 1990;111:765-772.
5. Iruela-Arispe ML, Bornstein P, Sage H: Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci USA 1991;88:5026-5030.
6. Tolsma SS, Volpert OV, Good DG, Frazier WA, Polverini PJ, Bouck N: Peptides from two separate domains of the matrix protein thrombospondin 1 have anti-angiogenic activity. J Cell Biol 1993;122:497-511.
7. DiPietro LA, Nebgen DR: Polverini PJ: Modulation of in vitro angiogenesis by genetic manipulation of endothelial cell thrombospondin. J Vasc Res 1994;31:178-185.
8. Rastinejad F, Polverini PJ, Bouck NP: Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 1989; 56:345-355.
9. Sheibani N, Frazier WA: Thrombospondin-1 expression in transformed endothelial cells restores abnormal phenotype and suppresses their tumorigenesis. Proc Natl Acad Sci USA 1995;92:6788-6792.
10. Castle VP, Dixit VM, Polverini PJ: Thrombospondin-1 suppresses tumorigenesis and angiogenesis in serum- and anchorage-independent NIH3T3 cells. Lab Invest 1997;77:51-61.
11. Yue TL, Wang X, Louden CS, Gupta S, Pillarietti K, Gu JL, Hart TK, Lysko PG, Feuerstein GZ: 2-Methoxyestradiol, an endogenous estrogen metabolite, induce apoptosis in endothelial cells and inhibits angiogenesis: Possible role for stress-activated protein kinase signaling pathway and fas expression. Mol Pharmacol 1997; 51:951-962.
12. Claesson-Welsh L, Welsh M, Ito N, Anand-Apte B, Soker S, Zetter B, O'Reilly M, Folkman J: Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc Natl Acad Sci USA 1998;95:5579-5583.
13. Nuñez G, Clarke MF: The Bcl-2 family of proteins: Regulators of cell death and survival. Trends Cell Biol 1994;4:399-403.
14. Kroemer G: The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 1997;3:614-620.
15. Schendel SL, Xie Z, Montal MO, Matsuyama S, Montal M, Reed JC: Channel formation by antiapoptotic protein Bcl-2. Proc Natl Acad Sci USA 1997;94:5113-5118.
16. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng T, Jones DP, Wang X: Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 1997;275: 1129-1132.
17. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA.: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995;376:37-43.
18. Hara H, Friedlander RM, Gagliardini V, Ayata C, Fink K, Huang Z, Shimizu-Sasamata M, Yuan J, Moskowitz MA: Inhibition of interleukin-1 beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 1997;94:2007-2012.
19. Nör JE, Christensen J, Mooney DJ, Polverini PJ: VEGF-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 1999;154:375-384.
20. Griscelli F, Li H, Bennaceur-Griscelli A, Soria J, Opolon P, Soria C, Perricaudet M, Yeh P, Lu H: Angiostatin gene transfer: Inhibition of tumor growth in vivo by blockage of endothelial cell profliferation associated with a mitosis arrest. Proc Natl Acad Sci USA 1998;95:6367-6372.
21. Guo N, Krutzsch HC, Inman JK, Roberts DD: Thrombospondin-1 and type I repeat peptides of thrombospondin-1 specifically induce apoptosis of endothelial cells. Cancer Res 1997;57: 1735-1742.
22. Villaschi S, Nicosia R: Paracrine interactions between fibroblasts and endothelial cells in a serum-free coculture model. Modulation of angiogenesis and collagen gel contraction. Lab Invest 1994;71:291-299.
23. Takahashi K, Sawasaki Y, Hata JI, Mukai K, Goto T: Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev Biol 1990;25:265-274.
24. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
25. Mitra RJ, Wrone-Smith T, Simonian P, Foreman KE, Nuñez G, Nickoloff BJ: Apoptosis in keratinocytes is not dependent on induction of differentiation. Lab Invest 1997;76:99-107.
26. Gong J, Traganos F, Darzynkiewicz Z: A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem 1994; 218:314-319.
27. Thornberry NA: Interleukin-1β converting enzyme. Methods Enzymol 1994;244:615-631.
28. Lomo J, Smeland EB, Krajewski S, Reed JC, Blomhoff HK: Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes. Cancer Res 1996;56:40-43.
29. Mooney DJ, Sano K, Kaufmann PM, Majahod K, Scloo B, Vacanti JP, Langer R: Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J Biomed Mater Res 1997;37:413-420.
30. Prochownik EV, O'Rourke K, Dixit VM: Expression and analysis of COOH-terminal deletions of the human thrombospondin molecule. J Cell Biol 1989;109:843-852.
31. Thronberry NA, Lazebnik Y: Caspases: Enemies within. Science 1998;281:1312-1316.
32. Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, McCulloch P, Pezzella F, Vialc CJ, Weidner N, Harris AL: Quantification of angiogenesis in solid tumors: An international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996;32A:2474-2484.
33. Polverini PJ: The pathophysiology of angiogenesis. Crit Rev Oral Biol Med 1995;6:230-247.
34. Ferrara N: Vascular endothelial growth factor. Eur J Cancer 1996;32A:2413-2422.
35. Gerber HP, Dixit V, Ferrara N: Vascular endothelial growth factor induces expression of the anti-apoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 1998;273: 13313-13316.